Introduction
The increased failure rate of BSI's CE marking assessments for medical devices in the European market this year is a critical issue that demands immediate attention. This analysis will systematically identify, validate, and address the root causes while considering both short-term and long-term implications for BSI and the medical device industry.
This analysis follows a structured approach covering issue identification, hypothesis generation, validation, and solution development.
Step 1
Clarifying Questions (3 minutes)
Why it matters: Regulatory changes could directly impact assessment criteria and failure rates. Expected answer: Yes, there have been updates to the Medical Device Regulation (MDR). Impact on approach: If confirmed, we'd need to focus on regulatory compliance and adaptation.
Why it matters: The magnitude of the increase helps prioritize the urgency of our response. Expected answer: A 20-30% increase in failure rates. Impact on approach: A significant increase would suggest systemic issues rather than isolated incidents.
Why it matters: Personnel changes could introduce inconsistencies in assessment methods. Expected answer: Some turnover in the assessment team, but no major restructuring. Impact on approach: If confirmed, we'd need to investigate training and standardization processes.
Why it matters: New or more complex devices could be more challenging to assess. Expected answer: An increase in AI-enabled and software-as-a-medical-device submissions. Impact on approach: If true, we'd need to focus on updating assessment criteria for emerging technologies.
Practice similar questions
Subscribe to access the full answer